Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide Synthesis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel liquid phase synthesis patent CN117820423A offers high purity palmitoyl pentapeptide-4 with scalable manufacturing and cost reduction potential for global supply chains.
Novel solid-phase synthesis reduces side reactions and improves purity for scalable amylin analogue manufacturing supply chains globally.
Patent CN115819493A reveals a novel acid-base washing method improving crude peptide purity by approximately 30%, offering cost-effective manufacturing for GLP-1 analogs.
Novel fragment condensation method reduces impurities and production costs significantly. Reliable supply chain partner for high purity polypeptide manufacturing processes.
Patent CN110964097B details a high-yield solid-phase fragment method for Exenatide, achieving over 99.7% purity and significantly reducing manufacturing costs.
Advanced all-solid-phase synthesis of Thymalfasin using amino resin and DMB-modified dipeptides. Delivers high purity and yield for reliable pharmaceutical intermediates supply.
Patent CN110894227A details a novel two-fragment solid-phase synthesis for Liraglutide, offering higher purity and reduced oily intermediates for reliable pharmaceutical manufacturing.
Novel liquid-phase synthesis for Tenipout peptide using soluble hydrophobic tags. Enhances purity and scalability for pharmaceutical intermediates manufacturing supply chains.
Patent CN113444150B reveals a novel solid-phase method for Plecanatide, offering superior yield and purity. Discover cost-effective manufacturing solutions for this GI drug.
Patent CN111378009A reveals a novel solid-phase synthesis for octreotide using aldehyde resin. This method simplifies processing, reduces side reactions, and offers cost-effective manufacturing solutions.
Novel liquid-phase synthesis of Nonapeptide-1 using DPBPA carrier technology. Reduces waste, enhances purity, and offers scalable solutions for cosmetic API intermediates manufacturing.
Novel alkaline hydrolysis method for Semaglutide backbone fragments. High purity, simplified steps, and cost-effective manufacturing for GLP-1 analog intermediates.
Patent CN116410260A reveals a high-purity liquid-phase synthesis for Fmoc-L-Orn(Boc)-Gly-OH, offering significant cost reduction in atosiban manufacturing and scalable production capabilities.
Novel protection-free method for L-Ala-L-Tyr ensures high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Patent CN118085036B enables aqueous cyclization reducing solvent waste. Offers supply chain reliability and cost reduction in peptide manufacturing for global partners.
Novel liquid-phase cyclization method ensures high purity and low racemization for scalable pharmaceutical intermediate manufacturing supply chains reducing costs significantly.
Patent CN108484461A reveals metal-free thioamide synthesis. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Novel patent CN114044813B details high-yield procatide preparation offering supply chain stability and significant cost reduction in API manufacturing for global partners.
Patent CN1513872A details high-yield liquid-phase thymopentin synthesis. Offers scalable production, reduced equipment costs, and superior purity for global pharmaceutical supply chains.
Novel one-pot isonitrile mediated ligation method for Semaglutide reduces purification steps and enhances supply chain reliability for pharmaceutical manufacturing.